Dean A Regier
Dean A Regier
BC Cancer - ARCC; SPPH - University of British Columbia
Verified email at
Cited by
Cited by
Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
JFP Bridges, AB Hauber, D Marshall, A Lloyd, LA Prosser, DA Regier, ...
Value in health 14 (4), 403-413, 2011
Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force
FR Johnson, E Lancsar, D Marshall, V Kilambi, A Mühlbacher, DA Regier, ...
Value in health 16 (1), 3-13, 2013
Evaluating health-related quality-of-life studies in paediatric populations
M De Civita, D Regier, AH Alamgir, AH Anis, MJ FitzGerald, CA Marra
Pharmacoeconomics 23 (7), 659-685, 2005
Handbook of statistics in clinical oncology
J Crowley, A Hoering
CRC Press, 2012
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
DA Regier, R Sunderji, LD Lynd, K Gin, CA Marra
CMAJ 174 (13), 1847-1852, 2006
An overview of economic evaluations for drugs used in rheumatoid arthritis
NJ Bansback, DA Regier, R Ara, A Brennan, K Shojania, JM Esdaile, ...
Drugs 65 (4), 473-496, 2005
Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals
D Tomlinson, U Bartels, J Gammon, PS Hinds, J Volpe, E Bouffet, ...
Cmaj 183 (17), E1252-E1258, 2011
Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment
DA Regier, SJ Peacock, R Pataky, K Van Der Hoek, GP Jarvik, J Hoch, ...
Cmaj 187 (6), E190-E197, 2015
Bayesian and classical estimation of mixed logit: an application to genetic testing
DA Regier, M Ryan, E Phimister, CA Marra
Journal of health economics 28 (3), 598-610, 2009
Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation …
CS Bennette, SB Trinidad, SM Fullerton, D Patrick, L Amendola, W Burke, ...
Genetics in Medicine 15 (11), 873-881, 2013
Multi-criteria decision analysis to support healthcare decisions
K Marsh, M Goetghebeur, P Thokala, R Baltussen
Springer International Publishing 10, 978-3, 2017
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability
DA Regier, JM Friedman, CA Marra
The American Journal of Human Genetics 86 (5), 765-772, 2010
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
E Pleasance, E Titmuss, L Williamson, H Kwan, L Culibrk, EY Zhao, ...
Nature Cancer 1 (4), 452-468, 2020
Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children
DA Regier, JM Friedman, N Makela, M Ryan, CA Marra
Clinical genetics 75 (6), 514-521, 2009
Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions
KA Phillips, PA Deverka, DA Marshall, S Wordsworth, DA Regier, ...
Value in Health 21 (9), 1033-1042, 2018
The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers
D Weymann, J Laskin, R Roscoe, KA Schrader, S Chia, S Yip, ...
Molecular genetics & genomic medicine 5 (3), 251-260, 2017
Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions
DA Regier, D Weymann, J Buchanan, DA Marshall, S Wordsworth
Value in Health 21 (9), 1043-1047, 2018
Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia
S Cheng, O Teuffel, MC Ethier, C Diorio, J Martino, C Mayo, D Regier, ...
British journal of cancer 105 (5), 606-611, 2011
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada
S Cressman, S Lam, MC Tammemagi, WK Evans, NB Leighl, DA Regier, ...
Journal of thoracic oncology 9 (10), 1449-1458, 2014
Cost-effectiveness of therapeutic hypothermia to treat neonatal encephalopathy
DA Regier, S Petrou, J Henderson, O Eddama, N Patel, B Strohm, ...
Value in Health 13 (6), 695-702, 2010
The system can't perform the operation now. Try again later.
Articles 1–20